The Current Ratio as of September 2024 (TTM) for Cognition Therapeutics, Inc. (CGTX) is 3.07

According to Cognition Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.07. This represents a change of -17.03% compared to the average of 3.70 of the last 4 quarters.

Cognition Therapeutics, Inc. (CGTX) Historical Current Ratio (quarterly & annually)

How has CGTX Current Ratio performed in the past?

The mean historical Current Ratio of Cognition Therapeutics, Inc. over the last ten years is 4.21. The current 3.07 Current Ratio has changed 7.20% with respect to the historical average. Over the past ten years (40 quarters), CGTX's Current Ratio was at its highest in in the December 2021 quarter at 7.50. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Cognition Therapeutics, Inc. (CGTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cognition Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cognition Therapeutics, Inc. (CGTX) Average Current Ratio

How has CGTX Current Ratio performed in the past?

The current Current Ratio of Cognition Therapeutics, Inc. (CGTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cognition Therapeutics, Inc. (CGTX) Current Ratio vs. Peers

How is CGTX’s Current Ratio compared to its peers?

Cognition Therapeutics, Inc.’s Current Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Eyenovia, Inc. (0.43), greater than TransCode Therapeutics, Inc. (1.25), less than Kodiak Sciences Inc. (10.59), greater than TFF Pharmaceuticals, Inc. (1.63), less than TScan Therapeutics, Inc. (7.77), greater than Cue Biopharma, Inc. (2.06), greater than Dermata Therapeutics, Inc. (2.73), greater than Gain Therapeutics, Inc. (2.84), less than aTyr Pharma, Inc. (6.07), greater than IN8bio, Inc. (2.66), less than Lantern Pharma Inc. (7.67), less than Cullinan Oncology, Inc. (0), less than Bolt Biotherapeutics, Inc. (28.87), less than Day One Biopharmaceuticals, Inc. (4.28), less than Lyra Therapeutics, Inc. (4.09), less than Autolus Therapeutics plc (3.60), less than null (18.50),

Build a custom stock screener for Cognition Therapeutics, Inc. (CGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cognition Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cognition Therapeutics, Inc. (CGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cognition Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.